Enanta Pharmaceuticals Inc (ENTA)

[dewophile]

ha!
seriously though the negative valuation is because it is viewed by some as a waste of money and this news won't cause enta to scrap their programs. and for those who view the RSV pipeline as a positive this is potential competition they may not have been aware of. I've talked about the shionogi program on here and getting fast track is totally expected I mean enta got it for both their rsv drugs in the clinic and this is no different, but the company doesn't include the shionogi drug in their presentation (it is about 2 years behind 938) like they do the ark drug or the pfe drug that recently got shelved so there really may not be much awareness. Incidentally ENTA got an upgrade when PFE stopped their RSV program, so some people are paying attention to the competition.